If you got a question, look no further.
We post the most common questions
in our FAQ section.
Please fill in the form below to receive a Free Sample of the Report.
In recent years, advances in new healthcare reform have boosted market demand
from China pharmaceuticals industryand driven growth in the demand from
pharmaceutical packaging industry. In 2014, the Chinese pharmaceutical packaging
market reached RMB72 billion, up 10.6% from a year earlier.
As a traditional form of pharmaceutical packaging bottle, pharmaceutical glass
bottle took up a large proportion of the Chinese pharmaceutical packaging market
in initial development stage of the packaging market. However, affected by
negative factors like the substitution of new packaging materials (plastics and
aluminum foil) and continuous decline in purchase prices of packaging materials
quoted by pharmaceutical companies due to reform in medical system, China
pharmaceutical glass packaging industry has developed sluggishly, with its
market share standing at estimated 45% or so for the time being.
Due to low barrier to entry, China’s pharmaceutical glass industry has been
large but not strong as a whole, with low and medium-end products struggling
with huge overcapacity and high-end products relying on imports. At present,
developed countries around the world all use level I waterproof neutral
borosilicate glass, while China still mostly adopts low borosilicate glass,
soda-lime glass and almost domestically unique “semi-neutral borosilicate
pharmaceutical glass” (its chemical stability cannot meet neutral requirements;
the heavy metal content in glass is not defined clearly; dimensions are not
The production of neutral borosilicate glass faces dual barriers of raw
materials and tube-making technology, which have been still controlled by
foreign companies so far, resulting in persistently high production costs and
limited applications. In 2012, German Schott AG, a world well-known
pharmaceutical glass company, together with Zhejiang Xinkang Pharmaceutical
Glass Co., Ltd., announced to establish a joint venture that would engage in
pharmaceutical packaging, an important sign marking localization of
pharmaceutical glass. But, even for the joint venture, it has to buy glass tube
produced by Schott abroad.
However, the defect of low borosilicate glass easily flaking causes safety risks
to health of users, so it is imperative to promote neutral borosilicate glass.
Market demand for neutral borosilicate glass pharmaceutical containers has been
growing by more than 20% over the past two years. More and more pharmaceutical
players started to use neutral borosilicate glass, especially for high
value-added products. For example, Buchang Pharma employs neutral borosilicate
glass packaging materials for all its Danhong Injections, and some innovative
R&D-oriented pharmaceutical companies like Jiangsu Hengrui Medicine Co., Ltd.
also adopt neutral borosilicate glass.
With years of development and competition, the Chinese pharmaceutical glass
business market still finds a relatively low level of concentration, but
competitively leading companies have emerged in some market segments, especially
in prefilled syringe market.
There are only five companies that have obtained assemblages for prefilled
syringes in China, i.e., foreign-funded BD and Gerresheimer and domestic
Shandong Weigao Group Medical Polymer, Shandong Zibo Minkang Pharmaceutical
Packing Co., Ltd. and Shandong Pharmaceutical Glass Co., Ltd.
By virtue of first-mover advantage and developed marketing network, Shandong
Weigao Group Medical Polymer sold about 85.85 million prefilled syringes in
2014, accounting for more than 50% of the market in China, followed by foreign
brands such as BD and Gerresheimer with market share of about 25%, and Zibo
Minkang Pharmaceutical and Shandong Pharmaceutical Glass (the remaining). In
addition, Shandong Weigao Group Medical Polymer still plans to implement the
50-million prefilled syringes project, which is expected to further raise the
company’s share in prefilled system market.
China Pharmaceutical Glass Packaging Industry Report, 2014-2017 highlights the
Status quo, market size, import & export, downstream demand and development
forecast of China pharmaceutical glass industry;
Status quo, competitive landscape and price of China prefilled syringe industry;
Operation, pharmaceutical glass business and development prospects of 4 global
and 6 domestic pharmaceutical glass packaging companies.
1 Overview of Pharmaceutical Glass Packaging Materials
1.1 Definition and Classification
1.2 Industry Chain
2 Development of China Pharmaceutical Glass Industry
2.1 Status Quo
2.2 Market Size
2.3 Competitive Landscape
2.4 Import & Export
2.5 Prefilled Injection System
2.5.1 Definition and Classification
2.5.2 Status Quo
2.5.3 Competitive Landscape
2.6 Downstream Demand
2.6.2 Blood Product
2.6.6 Recombinant Human Granulocyte Colony-stimulating Factor (rhG-CSF)
2.7 Development Trend
3 Major Pharmaceutical Glass Companies
3.1 Becton, Dickinson and Company
3.1.3 Revenue Structure
3.1.4 Pharmaceutical Packaging Materials Business
3.1.5 Business in China
3.2 Gerresheimer AG
3.2.3 Revenue Structure
3.2.4 Business in China
3.3 SCHOTT AG
3.3.3 Pharmaceutical Packaging Materials Business
3.3.4 Business in China
3.4 Nipro Medical Corporation
3.4.3 Revenue Structure
3.4.4 Pharmaceutical Packaging Materials Business
3.4.5 Business in China
22.214.171.124 ChengDuPingYuanNipro Pharmaceutical Packaging Co., Ltd.
126.96.36.199 Jilin NiproJiaheng Pharmaceutical Packaging Co., Ltd.
188.8.131.52 Anyang NiproChangda Pharmaceutical Packaging Co., Ltd.
3.5 Shandong Pharmaceutical Glass Co., Ltd
3.5.3 Revenue Structure
3.5.4 Gross Margin
3.5.5 Development Prospects and Forecast
3.6 Shandong Weigao Group Medical Polymer Co., Ltd.
3.6.3 Revenue Structure
3.6.4 Gross Margin
3.6.5 R&D and Investment
3.6.6 Major Customers
3.6.7 Pharmaceutical Packaging Materials Business
3.6.8 Development Prospects and Forecast
3.7 Cangzhou Four Stars Glass Co., Ltd.
3.8 Shandong Zibo Minkang Pharmaceutical Packing Co., Ltd.
3.9 Chongqing Zhengchuan Pharmaceutical Packaging Co., Ltd.
3.10 Linuo Glassworks Group
4 Summary and Forecast